Published online Dec 28, 2015. doi: 10.4254/wjh.v7.i30.2968
Peer-review started: May 4, 2015
First decision: July 6, 2015
Revised: November 26, 2015
Accepted: December 13, 2015
Article in press: December 15, 2015
Published online: December 28, 2015
Processing time: 243 Days and 15.7 Hours
Helicobacter pylori (H. pylori) is an ancient microorganism that has co-evolved with humans for over 60000 years. This bacterium typically colonizes the human stomach and it is currently recognized as the most common infectious pathogen of the gastroduodenal tract. Although its chronic infection is associated with gastritis, peptic ulcer, dysplasia, neoplasia, MALT lymphoma and gastric adenocarcinoma, it has been suggested the possible association of H. pylori infection with several extragastric effects including hepatobiliary and pancreatic diseases. Since a microorganism resembling H. pylori was detected in samples from patients with hepatobiliary disorders, several reports have been discussed the possible role of bacteria in hepatic diseases as hepatocellular carcinoma, cirrhosis and hepatic encephalopathy, nonalcoholic fatty liver disease and fibrosis. Additionally, studies have reported the possible association between H. pylori infection and pancreatic diseases, especially because it has been suggested that this infection could change the pancreatic physiology. Some of them have related a possible association between the microorganism and pancreatic cancer. H. pylori infection has also been suggested to play a role in the acute and chronic pancreatitis pathogenesis, autoimmune pancreatitis, diabetes mellitus and metabolic syndrome. Considering that association of H. pylori to liver and pancreas diseases needs further clarification, our work offers a review about the results of some investigations related to the potential pathogenicity of H. pylori in these extragastric diseases.
Core tip:Helicobacter pylori (H. pylori) has been associated with several extragastric manifestations, including liver and pancreas diseases. Evidence for its role in the pathogenesis of chronic liver diseases and liver carcinoma is supported by several clinical and experimental studies. Furthermore, epidemiologic and serology-based works have reported a possible association between the microorganism and pancreatic cancer. H. pylori infection has also been linked to the acute and chronic pancreatitis pathogenesis and it could be related to the development of autoimmune pancreatitis, diabetes mellitus and metabolic syndrome. This review summarizes recent findings on the possible role of H. pylori infection in the etiology of liver and pancreas disorders.